Cargando…

2021: the year [(177)Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines?: Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke

Detalles Bibliográficos
Autores principales: Herrmann, Ken, Kratochwil, Clemens, Fendler, Wolfgang P., Eiber, Matthias, Hustinx, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263423/
https://www.ncbi.nlm.nih.gov/pubmed/34021392
http://dx.doi.org/10.1007/s00259-021-05409-w
_version_ 1783719387329462272
author Herrmann, Ken
Kratochwil, Clemens
Fendler, Wolfgang P.
Eiber, Matthias
Hustinx, Roland
author_facet Herrmann, Ken
Kratochwil, Clemens
Fendler, Wolfgang P.
Eiber, Matthias
Hustinx, Roland
author_sort Herrmann, Ken
collection PubMed
description
format Online
Article
Text
id pubmed-8263423
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-82634232021-07-20 2021: the year [(177)Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines?: Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke Herrmann, Ken Kratochwil, Clemens Fendler, Wolfgang P. Eiber, Matthias Hustinx, Roland Eur J Nucl Med Mol Imaging Editorial Springer Berlin Heidelberg 2021-05-22 2021 /pmc/articles/PMC8263423/ /pubmed/34021392 http://dx.doi.org/10.1007/s00259-021-05409-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Editorial
Herrmann, Ken
Kratochwil, Clemens
Fendler, Wolfgang P.
Eiber, Matthias
Hustinx, Roland
2021: the year [(177)Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines?: Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
title 2021: the year [(177)Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines?: Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
title_full 2021: the year [(177)Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines?: Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
title_fullStr 2021: the year [(177)Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines?: Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
title_full_unstemmed 2021: the year [(177)Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines?: Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
title_short 2021: the year [(177)Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines?: Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
title_sort 2021: the year [(177)lu]lu-psma-617 rlt psma is ready for incorporation into clinical guidelines?: reply to “a perspective on the eanm procedure guidelines for radionuclide therapy with 177lu-labelled psma-ligands” by dr. germo gericke
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263423/
https://www.ncbi.nlm.nih.gov/pubmed/34021392
http://dx.doi.org/10.1007/s00259-021-05409-w
work_keys_str_mv AT herrmannken 2021theyear177lulupsma617rltpsmaisreadyforincorporationintoclinicalguidelinesreplytoaperspectiveontheeanmprocedureguidelinesforradionuclidetherapywith177lulabelledpsmaligandsbydrgermogericke
AT kratochwilclemens 2021theyear177lulupsma617rltpsmaisreadyforincorporationintoclinicalguidelinesreplytoaperspectiveontheeanmprocedureguidelinesforradionuclidetherapywith177lulabelledpsmaligandsbydrgermogericke
AT fendlerwolfgangp 2021theyear177lulupsma617rltpsmaisreadyforincorporationintoclinicalguidelinesreplytoaperspectiveontheeanmprocedureguidelinesforradionuclidetherapywith177lulabelledpsmaligandsbydrgermogericke
AT eibermatthias 2021theyear177lulupsma617rltpsmaisreadyforincorporationintoclinicalguidelinesreplytoaperspectiveontheeanmprocedureguidelinesforradionuclidetherapywith177lulabelledpsmaligandsbydrgermogericke
AT hustinxroland 2021theyear177lulupsma617rltpsmaisreadyforincorporationintoclinicalguidelinesreplytoaperspectiveontheeanmprocedureguidelinesforradionuclidetherapywith177lulabelledpsmaligandsbydrgermogericke